3Soustiel J F, Sviri G E, Mahamid E, et al. Cerebral blood flow and metabolism following decompressive craniectomy for control of increased intracranlal pressure [J]. Neurosurgery, 2010, 67 ( 1 ): 65-72.
8Tang J F, Chert P L, Tang E J, et al. Dexmedetomidine controls ag- itation and facilitates reliable, serial neurological examinations in a non-intubated patient with traumatic brain injury[J]. Neurocrit Care, 2011, 15(1):175-18I.
9Alkire M T. Quantitative EEG correlations with brain glucose metabolic rate during anesthesia in volunteers[J]. Anesthesiology, 1998, 89(2):323-333.
3Eser O, Cosar M, Fidan H, et al. The effect of dexmedetomidine in the prefrontal cortex of rabbits after subarachnoidal hemorrhage [J]. Neurol Psychiat Br, 2006, 13(4) : 189-194.
4Eser O, Fidan H, Coskun O, et al. Attenuation of vasospasm by demedeto- midine after experimental subarachnoidal haemorrhage in rabbits [J]. Turk J Med Sci, 2008,38(3) : 191-197.
5Eser O, Fidan H, Sahin O, et al. The influence of dexmedetomidine on ischemic rat hippocampus [ J ]. Brain Res, 2008,1218:250-256.
7Goyagi T, Nishikawa T, Tobe Y, et al. The combined neuroprotective effects of lidocaine and dexmedeto- midine after transient forebrain ischemia in rats [J]. Acta Anae Sc, 2009,53(9) : 1176-1183.
8Huang R, Chen Y, Yu A C, et al. Dexmedetomidine- induced stimulation of glutamine oxidation in astrocytes: A possible mechanism for its neuroprote- ctive activity [J]. J Cerebr Blood F Met, 2000,20 (6) : 895-898.
9Engelhard K, Wemer C, Eberspacher E, et al. The effect of the alpha 2- agonist dexmedetomidine and the N- methyl-D-aspartate antagonist S (+)- ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats [J]. Anesth Anal, 2003,96(2) : 524-531.
10Sanders R D, Sun P, Patel S, et al. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic- induced neuroapoptosis in the rat developing brain [J]. Acta Anae Sc, 2010,54(6) : 710-716.
